STOCK TITAN

Intrinsic’s Growing Transaction Opinions Practice Issued Two Public Company Fairness Opinions in 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

DENVER--(BUSINESS WIRE)-- Intrinsic LLC (“Intrinsic”), a fast-growing valuation and transaction advisory firm with employees located across a dozen U.S. cities, announced today that its Transaction Opinions practice issued two fairness opinions for publicly traded clients in 2022. Garrett Wilson, Managing Director commented, “We are proud and grateful that our publicly traded clients are clearly recognizing the best-in-class execution and value proposition that has been Intrinsic’s calling card for years in the private equity, family office and high net worth clientele communities. Evolving Delaware Court of Chancery legal precedents and increasing SEC scrutiny make independent fairness opinions a wise investment as a part of Boards of Directors’ financial diligence for significant or related party M&A. We look forward to continuing our strong momentum as a trusted provider of fairness opinions for publicly traded companies.”

Intrinsic rendered an opinion for the Board of Directors of Zynex Inc. (Nasdaq: ZYXI) that the $31 million in consideration to be paid to acquire Kestrel Labs was fair from a financial perspective.

Intrinsic rendered an opinion for the Board of Directors of FG Merger Corp (Nasdaq: FGMC), a special purpose acquisition corporation (“SPAC”), that the $100 million in maximum consideration in a merger with iCoreConnect, Inc. was fair from a financial perspective.

In line with Intrinsic’s strategy of developing best-in-class transaction advisory and valuation services, its Transaction Opinions practice has been built via key hires to serve as a trusted partner for independent and defensible fairness and solvency opinions to the Boards of Directors of publicly traded companies as they meet their fiduciary duties to shareholders. Intrinsic has assembled an impressive team of professionals from top firms with experience rendering or litigating over one hundred fiduciary opinions on transactions in many different industries ranging in size from tens of millions to tens of billions of dollars, many of which involved publicly traded companies.

About Intrinsic LLC

Intrinsic is a highly collaborative team of financial experts, providing expertise on valuation and transaction advisory matters. Members of the firm joined from roles in not just Big 4 accounting and international valuation firms, but also private equity, family office investing, C-suite executive leadership, investment banking, and M7 staff. Intrinsic’s own business is shaped and guided by a highly informed group of investors, including some of the most accomplished professionals and academics in the fields of private equity and entrepreneurial finance. For more information, visit www.intrinsicfirm.com.

Garrett Wilson

Manager Director, Transaction Opinions

gwilson@intrinsicfirm.com

(310) 955-0153

Source: Intrinsic LLC

ZYNEX INC

NASDAQ:ZYXI

ZYXI Rankings

ZYXI Latest News

ZYXI Stock Data

368.47M
15.72M
51.14%
31.25%
18%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
ENGLEWOOD

About ZYXI

zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. zynex neurodiagnostics develops devices for emg and eeg diagnostic applications within neurology disciplines. zynex medical's product line is fully developed, fda/ce cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. zynex monitoring solutions and zynex neurodiagnostics are currently both in the development stages without any significant revenues.